AndreiPikalovMD

PubMed

• The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
  Joseph F Goldberg, Cynthia Siu, Michael Tocco, Andrei Pikalov, Antony Loebel> ;The Journal of Clinical Psychiatry. 2023 Jun 7
• Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
  Michael Tocco, John W Newcomer, Yongcai Mao, Andrei Pikalov> ;CNS Spectrums. 2023 Dec 1
• 4 citations
  Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.
  Fabrizio Calisti, Agnese Cattaneo, Mariangela Calabrese, Yongcai Mao, Michael Tocco, Andrei Pikalov, Robert Goldman> ;International Clinical Psychopharmacology. 2022 Sep 1
• 4 citations
  Implementing Digital Technologies in Clinical Trials: Lessons Learned.
  Georgia Mitsi, Todd Grinnell, Suzanne Giordano, Thomas Goodin, Shahin Sanjar, Elizabeth Marble, Andrei Pikalov> ;Innovations in Clinical Neuroscience. 2022 Aug 12
• 5 citations
  Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia.
  Christoph U Correll, Michael Tocco, Jay Hsu, Robert Goldman, Andrei Pikalov> ;European Psychiatry. 2022 Mar 24
• 7 citations
  Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study.
  Christoph U Correll, Robert L Findling, Michael Tocco, Andrei Pikalov, Ling Deng, Robert Goldman> ;CNS Spectrums. 2022 Feb 1
• 3 citations
  Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
  Christoph U Correll, Michael Tocco, Andrei Pikalov, Jay Hsu, Robert Goldman> ;Schizophrenia Research. 2022 Feb 1
• 3 citations
  Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
  Melissa P. DelBello, Michael Tocco, Andrei Pikalov, Ling Deng, Robert Goldman> ;Journal of Child and Adolescent Psychopharmacology. 2021 Jul 29
• 7 citations
  Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
  Isabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, Jay Hsu, Michael Tocco, Andrei Pikalov, Robert Goldman> ;European Psychiatry. 2021 May 10
• 9 citations
  Major depressive disorder with mixed features and treatment response to lurasidone: A symptom network model.
  Joseph F. Goldberg, Cynthia Siu, Yongcai Mao, Joyce Tsai, Andrei Pikalov, Joseph R. Calabrese, Antony Loebel> ;Journal of Affective Disorders. 2020 Dec 1
• 3 citations
  Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
  Brian J. Miller, Andrei Pikalov, Cynthia Siu, Michael Tocco, Joyce Tsai, Philip D. Harvey, John W. Newcomer, Antony Loebel> ;Comprehensive Psychiatry. 2020 Oct 1
• 6 citations
  Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia.
  Michael Tocco, John W. Newcomer, Yongcai Mao, Andrei Pikalov, Antony Loebel> ;CNS Spectrums. 2020 Sep 14
• 8 citations
  Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Contr...
  Manpreet K. Singh, Andrei Pikalov, Cynthia Siu, Michael Tocco, Antony Loebel> ;Journal of Child and Adolescent Psychopharmacology. 2020 May 8
• 9 citations
  Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
  Greg Mattingly, Peter Haddad, Michael Tocco, Jane Xu, Debra Phillips, Andrei Pikalov, Antony Loebel> ;BMC Psychiatry. 2020 May 5
• 7 citations
  Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled ...
  Anita H. Clayton, Joyce Tsai, Yongcai Mao, Andrei Pikalov, Antony Loebel> ;The Journal of Clinical Psychiatry. 2018 Aug 7
• 29 citations
  Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder
  Joseph R. Calabrese, Andrei Pikalov, Caroline Streicher, Josephine Cucchiaro, Yongcai Mao, Antony Loebel> ;European Neuropsychopharmacology. 2017 Sep 1
• 7 citations
  Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial.
  John J. Sramek, Antony Loebel, Michael P. Murphy, Yongcai Mao, Andrei Pikalov, Neal R. Cutler> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2017 Aug 1
• 8 citations
  Efficacy of Lurasidone in the Treatment of Agitation: a Post Hoc Analysis of Five Short-term Studies in Acutely Ill Patients with Schizophrenia
  Michael H. Allen, Leslie Citrome, Andrei Pikalov, Jay Hsu, Antony Loebel> ;General Hospital Psychiatry. 2017 Jul 1
• 12 citations
  Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.
  Joyce Tsai, Michael E. Thase, Yongcai Mao, Daisy Ng-Mak, Andrei Pikalov, Antony Loebel> ;CNS Spectrums. 2017 Mar 30
• 9 citations
  Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
  Alan C. Swann, Maurizio Fava, Joyce Tsai, Yongcai Mao, Andrei Pikalov, Antony Loebel> ;CNS Spectrums. 2017 Mar 16
• 17 citations
  Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment
  Andrei Pikalov, Joyce Tsai, Yongcai Mao, Robert Silva, Josephine Cucchiaro, Antony Loebel> ;International Journal of Bipolar Disorders. 2017 Mar 2
• 17 citations
  Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
  Martha Sajatovic, Brent P. Forester, Joyce Tsai, H. Kroger, Andrei Pikalov, Josephine Cucchiaro, Antony Loebel> ;The Journal of Clinical Psychiatry. 2016 Oct 26
• 34 citations
  Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
  Trisha Suppes, H. Kroger, Andrei Pikalov, Antony Loebel> ;Journal of Psychiatric Research. 2016 Jul 1
• 6 citations
  Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
  George A. Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov, Antony Loebel> ;BMC Psychiatry. 2016 Jun 1
• 8 citations
  Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials
  Krithika Rajagopalan, Elizabeth D. Bacci, Daisy Ng-Mak, Kathy Wyrwich, Andrei Pikalov, Antony Loebel> ;BMC Psychiatry. 2016 May 23
• Join now to see all